Browsing Centre for Environmental and Preventive Medicine (CEPM) by Author "Huttly, WJ"
Now showing items 1-10 of 10
-
Antenatal Screening for Down Syndrome Using Serum Placental Growth Factor with the Combined, Quadruple, Serum Integrated and Integrated Tests
Wald, NJ; Bestwick, JP; George, LM; Huttly, WJ (2012-10-03) -
Antenatal screening for Down's syndrome: Revised nuchal translucency upper truncation limit due to improved precision of measurement
Vale, SH; Huttly, WJ; Wald, NJ (2021) -
Efficacy, safety profile, and immunogenicity of alglucosidase alfa produced at the 4,000-liter scale in US children and adolescents with Pompe disease: ADVANCE, a phase IV, open-label, prospective study Response
Wald, NJ; Huttly, WJ; Bestwick, JP; Old, R; Morris, JK; Cheng, R; Aquilina, J; Peregrine, E; Roberts, D; Alfirevic, Z (2018-10) -
Prenatal reflex DNA screening for trisomies 21, 18, and 13
Wald, NJ; Huttly, WJ; Bestwick, JP; Old, R; Morris, JK; Cheng, R; Aquilina, J; Peregrine, E; Roberts, D; Alfirevic, Z (2018-08) -
Prenatal screening for Down syndrome in twin pregnancies: Estimates of screening performance based on 61 affected and 7302 unaffected twin pregnancies
Wald, NJ; Bestwick, JP; Huttly, WJ; Aldis, J; Borrell, A; Goodburn, S; Mills, I (2018-12) -
Prenatal screening for Down syndrome in twin pregnancies: Estimates of screening performance based on 61 affected and 7302 unaffected twin pregnancies (vol 38, pg 1079, 2018)
Wald, NJ; Bestwick, JP; Huttly, WJ; Aldis, J; Borrell, A; Goodburn, S; Mills, I (2019-05) -
Prevention of Neural Tube Defects: A Cross-Sectional Study of the Uptake of Folic Acid Supplementation in Nearly Half a Million Women
Bestwick, JP; Huttly, WJ; Morris, JK; Wald, NJ (2014-02-19) -
Serum marker truncation limits in first trimester antenatal screening for trisomy 18
Bestwick, JP; Huttly, WJ; Wald, NJ (2018-12) -
A simple method to allow for guanine-cytosine amplification error in prenatal DNA screening for trisomy 18
Wald, NJ; Bestwick, JP; Lau, KW; Huttly, WJ; Ke, W; Cheng, R; Old, RW (2019-09) -
Specifying a Gold Standard for the Validation of Fetal Fraction Estimation in Prenatal Screening.
Wald, NJ; Lau, KW; Bestwick, JP; Old, RW; Huttly, WJ; Cheng, R (2018-09)BACKGROUND: An estimate of fetal fraction (FF) is needed for DNA-based screening for trisomy 21 and other aneuploidies, but there is no gold standard to validate FF measurement methods. We specify a gold standard and use ...